| Dr Ian B Walters, MD | |
|
5 Research Pkwy, Wallingford, CT 06492-1951 | |
| (203) 677-5752 | |
| (203) 677-6691 |
| Full Name | Dr Ian B Walters |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 5 Research Pkwy, Wallingford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316271471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 196684 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ian B Walters, MD 190 Governors Ln, Fairfield, CT 06824-2106 Ph: (203) 292-9254 | Dr Ian B Walters, MD 5 Research Pkwy, Wallingford, CT 06492-1951 Ph: (203) 677-5752 |
News Archive
The U.S. Department of Agriculture (USDA) Food and Nutrition Service has selected Abt Associates to lead a team evaluating a ground-breaking pilot program aimed at encouraging healthier eating among lower-income Americans. The Healthy Incentives Pilot (HIP) will enroll households in Hampden County, Massachusetts that participate in the Supplemental Nutrition Assistance Program (SNAP, formerly known as the Food Stamp Program).
Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a £2.25M Translation Award by the Wellcome Trust to develop its SASPject PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumoniae.
Unilife Medical Solutions Limited today announced the filing of patent applications in the United States ("US") for a new ready-to-fill syringe product to be marketed as the Unifill™ Select. Unilife is confident that this new pipeline product, which is to be primarily targeted for use with vaccines, can further expand the Company's ability to penetrate the pharmaceutical market for prefilled syringes.
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration in cardiovascular diseases, central nervous system injuries, ophthalmic indications and dermal wounds, announced the pricing of its previously announced underwritten public offering of 11,500,000 units of its securities at a public offering price of $0.41 per unit.
A new study analyzes the impact of non-pharmaceutical interventions in the United States against SARS-CoV-2 transmission.
› Verified 9 days ago
Anatoly Braylovsky, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 850 N Main Street Ext, Building 2 Suite 1b, Wallingford, CT 06492 Phone: 203-269-4200 Fax: 203-269-8800 | |
Henry Bear Hofbauer, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 850 N Main Street Ext, Building 2, Suite C3, Wallingford, CT 06492 Phone: 203-265-6522 Fax: 203-265-5605 | |
Alla Bernshteyn, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 67 Masonic Ave, 1st Floor, Wallingford, CT 06492 Phone: 203-265-0355 Fax: 203-265-7413 | |
Dr. Richard Alexander Bugliari, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1062 Barnes Rd, Ste 300, Wallingford, CT 06492 Phone: 203-265-9831 Fax: 203-265-2977 | |
Dr. Colleen Sherkow, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 863 N Main Street Ext, Suite 103, Wallingford, CT 06492 Phone: 203-694-5500 Fax: 203-694-5520 | |
Dr. Muhammad K. Al Mounayer, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: Gaylord Hospital, Gaylord Farm Rd., Wallingford, CT 06492 Phone: 203-284-2800 Fax: 203-679-3598 | |
Allison Padegimas, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1062 Barnes Rd Ste 300, Wallingford, CT 06492 Phone: 203-265-9831 |